These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 28393558)
61. Severe Toxicity to the New Psychoactive Substances 3-Hydroxyphencyclidine and N-Ethylhexedrone: an Analytically Confirmed Case Report. Dunlop LC; Wood D; Archer J; Hudson S; Dargan P J Med Toxicol; 2020 Jan; 16(1):67-70. PubMed ID: 31482320 [TBL] [Abstract][Full Text] [Related]
62. "Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York. Adams AJ; Banister SD; Irizarry L; Trecki J; Schwartz M; Gerona R N Engl J Med; 2017 Jan; 376(3):235-242. PubMed ID: 27973993 [TBL] [Abstract][Full Text] [Related]
63. [Etiology of initially unexplained confusion of excitability in deadly nightshade poisoning with suicidal intent. Symptoms, differential diagnosis, toxicology and physostigmine therapy of anticholinergic syndrome]. Heindl S; Binder C; Desel H; Matthies U; Lojewski I; Bandelow B; Kahl GF; Chemnitius JM Dtsch Med Wochenschr; 2000 Nov; 125(45):1361-5. PubMed ID: 11109424 [TBL] [Abstract][Full Text] [Related]
64. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN). Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; Sedefov R; Dargan PI; Clin Toxicol (Phila); 2015 Nov; 53(9):893-900. PubMed ID: 26503789 [TBL] [Abstract][Full Text] [Related]
65. Supraventricular tachyarrhythmia associated with baclofen overdose. Roberge RJ; Martin TG; Hodgman M; Benitez JG; Brunswick JE J Toxicol Clin Toxicol; 1994; 32(3):291-7. PubMed ID: 8007036 [TBL] [Abstract][Full Text] [Related]
66. The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism. Finlay DB; Mackie W; Webb HDJ; Thomsen LR; Nimick M; Rosengren RJ; Marusich JA; Glass M; Wiley JL Pharmacol Biochem Behav; 2023 Feb; 223():173530. PubMed ID: 36805861 [TBL] [Abstract][Full Text] [Related]
68. UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes. Li J; Liu C; Li T; Hua Z Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 28992356 [TBL] [Abstract][Full Text] [Related]
69. Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA. Finlay DB; Manning JJ; Ibsen MS; Macdonald CE; Patel M; Javitch JA; Banister SD; Glass M ACS Chem Neurosci; 2019 Oct; 10(10):4350-4360. PubMed ID: 31513380 [TBL] [Abstract][Full Text] [Related]
70. Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L-valine or L-tert-leucine. Wouters E; Mogler L; Cannaert A; Auwärter V; Stove C Drug Test Anal; 2019 Aug; 11(8):1183-1191. PubMed ID: 31021521 [TBL] [Abstract][Full Text] [Related]
71. Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service. Waugh J; Najafi J; Hawkins L; Hill SL; Eddleston M; Vale JA; Thompson JP; Thomas SH Clin Toxicol (Phila); 2016 Jul; 54(6):512-8. PubMed ID: 27091041 [TBL] [Abstract][Full Text] [Related]
72. Freeze-thaw stability and long-term stability of 84 synthetic cannabinoids in serum. Hess C; Krueger L; Unger M; Madea B Drug Test Anal; 2017 Oct; 9(10):1506-1511. PubMed ID: 27863089 [TBL] [Abstract][Full Text] [Related]
73. Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation. Daubert GP; Mabasa VH; Leung VW; Aaron C J Med Toxicol; 2007 Jun; 3(2):56-60. PubMed ID: 18072161 [TBL] [Abstract][Full Text] [Related]
74. Schedules of Controlled Substances: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA into Schedule I. Final rule. Drug Enforcement Administration, Department of Justice Fed Regist; 2016 Sep; 81(172):61130-3. PubMed ID: 27632803 [TBL] [Abstract][Full Text] [Related]
75. Treatment of caffeine toxicity with metoprolol. Li SF; Edwards L; Nguyen V Am J Emerg Med; 2019 Mar; 37(3):562.e5-562.e10. PubMed ID: 30514596 [TBL] [Abstract][Full Text] [Related]
76. The identification and quantification of synthetic cannabinoids seized in New Zealand in 2017. Somerville RF; Hassan VR; Kolbe E; Partington HK; Walsh KAJ; Kappatos DC; Johnson CS Forensic Sci Int; 2019 Jul; 300():19-27. PubMed ID: 31063884 [TBL] [Abstract][Full Text] [Related]
77. Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway. Vallersnes OM; Persett PS; Øiestad EL; Karinen R; Heyerdahl F; Hovda KE Clin Toxicol (Phila); 2017 Aug; 55(7):636-644. PubMed ID: 28406320 [TBL] [Abstract][Full Text] [Related]
79. Synthetic cannabinoids in e-liquids: A proton and fluorine NMR analysis from a conventional spectrometer to a compact one. Wu N; Danoun S; Balayssac S; Malet-Martino M; Lamoureux C; Gilard V Forensic Sci Int; 2021 Jul; 324():110813. PubMed ID: 33993010 [TBL] [Abstract][Full Text] [Related]
80. [Acute methoxetamine intoxication--a case report with serum and urine concentrations]. Łukasik-Głebocka M; Sommerfeld K; Tezyk A; Zielińska-Psuja B; Druzdz A Przegl Lek; 2013; 70(8):671-3. PubMed ID: 24466717 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]